Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention : Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography
Copyright © 2023 Elsevier Masson SAS. All rights reserved..
BACKGROUND: Recent randomized trials have demonstrated a consistent reduction in recurrent stroke after percutaneous transcatheter patent foramen ovale closure versus medical therapy in patients with recent cryptogenic stroke.
AIM: To compare the safety and efficacy of intracardiac echocardiography-guided and microprobe transoesophageal echocardiography-guided patent foramen ovale closure under local anaesthesia with transoesophageal echocardiography-guided patent foramen ovale closure under general anaesthesia.
METHODS: This prospective observational single-centre study included 194 consecutive patients scheduled for patent foramen ovale closure for secondary prevention of stroke from February 2018 to December 2019. Patients were asked to choose between an intracardiac echocardiography-guided, microprobe transoesophageal echocardiography-guided or transoesophageal echocardiography-guided procedure. The primary endpoint was the rate of successful closure at 6 months, defined as correct positioning of the device without severe shunt on 6-month contrast echocardiography.
RESULTS: Successful closure was high and did not differ between groups: 97.8% (95% confidence interval 88.5-99.9%) in the intracardiac echocardiography-guided group versus 96.9% (95% confidence interval 83.8-99.9%) in the microprobe transoesophageal echocardiography-guided group and 99.1% (95% confidence interval 95.3-99.9%) in the transoesophageal echocardiography-guided group (P=0.63). Adverse events related to patent foramen ovale closure were low and did not differ between groups.
CONCLUSION: Our preliminary real-world experience suggests good efficacy and safety with intracardiac echocardiography and microprobe transoesophageal echocardiography guidance compared with conventional transoesophageal echocardiography guidance for percutaneous transcatheter patent foramen ovale closure in recurrent stroke prevention.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Archives of cardiovascular diseases - (2023) vom: 29. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Reibel, Iphigénie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cryptogenic stroke |
|---|
| Anmerkungen: |
Date Revised 14.10.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.acvd.2023.08.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363315322 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363315322 | ||
| 003 | DE-627 | ||
| 005 | 20231226093058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.acvd.2023.08.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM363315322 | ||
| 035 | |a (NLM)37838576 | ||
| 035 | |a (PII)S1875-2136(23)00171-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Reibel, Iphigénie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention |b Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a BACKGROUND: Recent randomized trials have demonstrated a consistent reduction in recurrent stroke after percutaneous transcatheter patent foramen ovale closure versus medical therapy in patients with recent cryptogenic stroke | ||
| 520 | |a AIM: To compare the safety and efficacy of intracardiac echocardiography-guided and microprobe transoesophageal echocardiography-guided patent foramen ovale closure under local anaesthesia with transoesophageal echocardiography-guided patent foramen ovale closure under general anaesthesia | ||
| 520 | |a METHODS: This prospective observational single-centre study included 194 consecutive patients scheduled for patent foramen ovale closure for secondary prevention of stroke from February 2018 to December 2019. Patients were asked to choose between an intracardiac echocardiography-guided, microprobe transoesophageal echocardiography-guided or transoesophageal echocardiography-guided procedure. The primary endpoint was the rate of successful closure at 6 months, defined as correct positioning of the device without severe shunt on 6-month contrast echocardiography | ||
| 520 | |a RESULTS: Successful closure was high and did not differ between groups: 97.8% (95% confidence interval 88.5-99.9%) in the intracardiac echocardiography-guided group versus 96.9% (95% confidence interval 83.8-99.9%) in the microprobe transoesophageal echocardiography-guided group and 99.1% (95% confidence interval 95.3-99.9%) in the transoesophageal echocardiography-guided group (P=0.63). Adverse events related to patent foramen ovale closure were low and did not differ between groups | ||
| 520 | |a CONCLUSION: Our preliminary real-world experience suggests good efficacy and safety with intracardiac echocardiography and microprobe transoesophageal echocardiography guidance compared with conventional transoesophageal echocardiography guidance for percutaneous transcatheter patent foramen ovale closure in recurrent stroke prevention | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cryptogenic stroke | |
| 650 | 4 | |a Intracardiac echography | |
| 650 | 4 | |a Microprobe transoesophageal echocardiography | |
| 650 | 4 | |a Multiplane transoesophageal echocardiography | |
| 650 | 4 | |a Patent foramen ovale | |
| 650 | 4 | |a Structural heart disease | |
| 700 | 1 | |a Hauguel-Moreau, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Guedeney, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Hage, Georges |e verfasserin |4 aut | |
| 700 | 1 | |a Hammoudi, Nadjib |e verfasserin |4 aut | |
| 700 | 1 | |a Duthoit, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Zeitouni, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Lattuca, Benoit |e verfasserin |4 aut | |
| 700 | 1 | |a Kernéis, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Collet, Jean-Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Silvain, Johanne |e verfasserin |4 aut | |
| 700 | 1 | |a Montalescot, Gilles |e verfasserin |4 aut | |
| 700 | 0 | |a ACTION Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of cardiovascular diseases |d 2008 |g (2023) vom: 29. Sept. |w (DE-627)NLM178732060 |x 1875-2128 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:29 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.acvd.2023.08.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 29 |c 09 | ||